Felipe Batalini, M.D.

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Astrazeneca
    Topic: 
    PARPi
    Date added: 
    11/11/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Merck
    Topic: 
    PARPi
    Date added: 
    11/11/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Daiichi-Sankyo
    Topic: 
    Antibody-drug conjugates
    Date added: 
    11/11/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Novartis
    Topic: 
    CDK4/6i
    Date added: 
    11/11/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Illumina/Grail
    Topic: 
    DNA sequencing
    Date added: 
    11/11/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    CARIS
    Topic: 
    DNA sequencing
    Date added: 
    11/11/2023
  • Attribution: 
    Self
    Type of financial relationship: 
    Financial Support
    Ineligible company: 
    Foundation Medicine
    Topic: 
    DNA sequencing
    Date added: 
    11/11/2023
Return to BTF Best of ASH & SABCS 2024, Phoenix